The purpose of this activity is to inform electrophysiologists, cardiologists, and
other members of the cardiac care team of new developments in pharmacologic and nonpharmacologic
strategies to achieve normal sinus rhythm in patients with atrial fibrillation (AF).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2008 Published by Elsevier Inc. All rights reserved.
